دورية أكاديمية
Evaluation of corticophobia in asthmatic patients.
| العنوان: | Evaluation of corticophobia in asthmatic patients. |
|---|---|
| المؤلفون: | Yakar HI; Department of Chest Disease, Faculty of Medicine, Tokat Gaziosmanpasa University, Tokat, Turkey., Kanbay A; Department of Chest Disease, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey. |
| المصدر: | Nigerian journal of clinical practice [Niger J Clin Pract] 2020 Aug; Vol. 23 (8), pp. 1033-1038. |
| نوع المنشور: | Evaluation Study; Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Medknow Publications Country of Publication: India NLM ID: 101150032 Publication Model: Print Cited Medium: Internet ISSN: 1119-3077 (Print) NLM ISO Abbreviation: Niger J Clin Pract Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Mumbai : Medknow Publications Original Publication: [Lagos?] : Medical and Dental Consultants' Association of Nigeria |
| مواضيع طبية MeSH: | Fear* , Health Knowledge, Attitudes, Practice*, Adrenal Cortex Hormones/*therapeutic use , Anti-Asthmatic Agents/*therapeutic use , Asthma/*drug therapy , Medication Adherence/*psychology , Phobic Disorders/*psychology, Administration, Inhalation ; Adrenal Cortex Hormones/adverse effects ; Adult ; Anti-Asthmatic Agents/adverse effects ; Asthma/psychology ; Female ; Humans ; Male ; Medication Adherence/statistics & numerical data ; Middle Aged ; Phobic Disorders/epidemiology ; Phobic Disorders/etiology ; Surveys and Questionnaires |
| مستخلص: | Background: Inhaler corticosteroids (ICS) are the most commonly used antiinflammatory drugs in the treatment of asthma. Although systemic adverse effects are minimal, patients hesitate to use ICS for a long time because of corticophobia. There is no study evaluating corticophobia via Likert-type appendix among the asthmatic patients. Aim: In this study, it was aimed to evaluate the fears and beliefs about ICS in asthmatic patients. Subjects and Methods: Between December 2017 and January 2018, 150 stable asthmatic patients were included in the study. Demographic data (age, education, smoking history, etc.) and asthma-related data (pulmonary function test, drug use) were recorded. The appendix of TOPICOP study applied to the patients with asthma which was composed of 10 questions (five questions about fear of ICS and five questions about beliefs of ICS). Results: The rate of ICS maintain in stable asthmatic patients was found to be 66.6%. According to the survey results, 68% of the patients believed that ICS may lead to weight gain, 52% believed that ICS may lead to infection, 73% believed that ICS may pass into bloodstream, and 67.3% believed that ICS may damage the lungs. It was also found that 90.7% needed to be informed about ICS and 67.3% wanted to cut the ICS drug as soon as possible. Conclusion: We found that treatment adherence may increase, if physicians allocate more time to asthma patients to inform about ICS beneficial effects at the initiating of ICS treatment and control visits. Competing Interests: None |
| فهرسة مساهمة: | Keywords: Asthma; appendix; corticophobia; inhaled corticosteroid; treatment |
| المشرفين على المادة: | 0 (Adrenal Cortex Hormones) 0 (Anti-Asthmatic Agents) |
| تواريخ الأحداث: | Date Created: 20200814 Date Completed: 20200911 Latest Revision: 20220416 |
| رمز التحديث: | 20240628 |
| DOI: | 10.4103/njcp.njcp_341_19 |
| PMID: | 32788477 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1119-3077 |
|---|---|
| DOI: | 10.4103/njcp.njcp_341_19 |